2024年12月,国家医保局发布了《妇科类医疗服务价格项目立项指南（试行）》,这是深化医药卫生体制改革的重要一步,也是医疗服务价格管理从过去侧重医疗服务的具体操作流程,向注重服务产出和价值体现的重要转型。该指南以服务产出为导向,将原有的妇科类价格项目整合为三类84项,实现了项目数量精简和项目内涵清晰,推动了价格项目的规范化和标准化。妇科类立项指南的实施,对于妇科医疗服务价值回归、保障女性全生命周期健康权益也具有重要的意义。本文分析了我国现行价格体系存在的突出问题,解读了本次妇科类立项指南的编制思路和主要特点,并以四川省的实践为例,详细介绍了地方对接国家指南的具体路径和挑战,为深化医疗服务价格改革提供参考。

In December 2024, the National Healthcare Security Administration released the Guideline for Establishing Gynecological Medical Service Price Items (Trial). This marks a significant step in deepening the reform of the healthcare system and represents a pivotal shift from a focus on the specific operational procedures of medical services to an emphasis on service output and value demonstration in medical service price management. Guided by service output, the guideline integrates the original gynecological service price items into three categories comprising 84 items. The guideline significantly streamlined the number of projects and clarified their definitions, thereby promoting standardization and normalization of pricing. The implementation of this guideline is of great significance for restoring the true value of gynecological medical services and safeguarding women's health rights across their entire life cycle. This article analyzes the prominent issues in China's current pricing system, interprets the design philosophy and key features of the gynecological guideline, takes practice in Sichuan Province as an example to provide a detailed introduction to the specific path and challenges of local adaptation of national guidelines, thus offering reference for further advancing medical service price reform.